Davita Healthcare Partners Inc. (DVA)

$126.11

-1.53

(-1.2%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Davita Healthcare Partners Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 2.87B → 3.14B (in $), with an average increase of 3.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 246.63M → 150.66M (in $), with an average decrease of 38.9% per quarter

Performance

  • $125.71
    $128.57
    $126.11
    downward going graph

    0.32%

    Downside

    Day's Volatility :2.22%

    Upside

    1.91%

    downward going graph
  • $71.51
    $141.54
    $126.11
    downward going graph

    43.3%

    Downside

    52 Weeks Volatility :49.48%

    Upside

    10.9%

    downward going graph

Returns

PeriodDavita Healthcare Partners Inc.Sector (Health Care)S&P500
3 Months
21.09%
-0.7%
5.0%
6 Months
62.1%
6.6%
16.4%
1 Year
52.88%
3.7%
20.9%
3 Years
15.22%
14.0%
20.0%

Highlights

Market Capitalization
11.3B
Book Value
$11.89
Earnings Per Share (EPS)
7.42
PE Ratio
17.49
PEG Ratio
1.16
Wall Street Target Price
132.0
Profit Margin
5.7%
Operating Margin TTM
12.16%
Return On Assets TTM
5.92%
Return On Equity TTM
38.53%
Revenue TTM
12.1B
Revenue Per Share TTM
133.72
Quarterly Revenue Growth YOY
7.8%
Gross Profit TTM
3.4B
EBITDA
2.3B
Diluted Eps TTM
7.42
Quarterly Earnings Growth YOY
1.2
EPS Estimate Current Year
9.01
EPS Estimate Next Year
10.08
EPS Estimate Current Quarter
1.59
EPS Estimate Next Quarter
1.67

Analyst Recommendation

Hold
    6%Buy
    53%Hold
    40%Sell
Based on 15 Wall street analysts offering stock ratings for Davita Healthcare Partners Inc.(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
00
Hold
8
8
10
Sell
6
6
6

Analyst Forecast

What analysts predicted

Upside of 4.67%

Current $126.11
Target $132.00

Company Financials

FY18Y/Y Change
Revenue
11.4B
↑ 4.86%
Net Income
790.1M
↑ 19.06%
Net Profit Margin
6.93%
↑ 0.83%
FY19Y/Y Change
Revenue
11.4B
↓ 0.14%
Net Income
811.0M
↑ 2.65%
Net Profit Margin
7.12%
↑ 0.19%
FY20Y/Y Change
Revenue
11.6B
↑ 1.42%
Net Income
773.6M
↓ 4.6%
Net Profit Margin
6.7%
↓ 0.42%
FY21Y/Y Change
Revenue
11.6B
↑ 0.59%
Net Income
978.5M
↑ 26.47%
Net Profit Margin
8.42%
↑ 1.72%
FY22Y/Y Change
Revenue
11.6B
↓ 0.08%
Net Income
768.2M
↓ 21.49%
Net Profit Margin
6.62%
↓ 1.8%
FY23Y/Y Change
Revenue
12.1B
↑ 4.57%
Net Income
691.5M
↓ 9.98%
Net Profit Margin
5.7%
↓ 0.92%
Q3 FY22Q/Q Change
Revenue
2.9B
↑ 0.75%
Net Income
164.7M
↓ 26.74%
Net Profit Margin
5.59%
↓ 2.09%
Q4 FY22Q/Q Change
Revenue
2.9B
↓ 1.08%
Net Income
113.2M
↓ 31.29%
Net Profit Margin
3.88%
↓ 1.71%
Q1 FY23Q/Q Change
Revenue
2.9B
↓ 1.51%
Net Income
170.7M
↑ 50.82%
Net Profit Margin
5.94%
↑ 2.06%
Q2 FY23Q/Q Change
Revenue
3.0B
↑ 4.44%
Net Income
178.7M
↑ 4.7%
Net Profit Margin
5.96%
↑ 0.02%
Q3 FY23Q/Q Change
Revenue
3.1B
↑ 4.03%
Net Income
246.6M
↑ 38.02%
Net Profit Margin
7.9%
↑ 1.94%
Q4 FY23Q/Q Change
Revenue
3.1B
↑ 0.78%
Net Income
150.7M
↓ 38.91%
Net Profit Margin
4.79%
↓ 3.11%
FY18Y/Y Change
Total Assets
19.1B
↑ 0.86%
Total Liabilities
14.1B
↑ 7.87%
FY19Y/Y Change
Total Assets
17.3B
↓ 9.41%
Total Liabilities
13.8B
↓ 1.89%
FY20Y/Y Change
Total Assets
17.0B
↓ 1.87%
Total Liabilities
14.1B
↑ 2.03%
FY21Y/Y Change
Total Assets
17.1B
↑ 0.78%
Total Liabilities
14.8B
↑ 4.67%
FY22Y/Y Change
Total Assets
16.9B
↓ 1.13%
Total Liabilities
14.7B
↓ 0.32%
FY23Y/Y Change
Total Assets
17.6B
↑ 4.08%
Total Liabilities
14.9B
↑ 1.17%
Q3 FY22Q/Q Change
Total Assets
17.0B
↓ 0.81%
Total Liabilities
14.9B
↓ 0.34%
Q4 FY22Q/Q Change
Total Assets
16.9B
↓ 0.2%
Total Liabilities
14.7B
↓ 1.25%
Q1 FY23Q/Q Change
Total Assets
16.7B
↓ 1.18%
Total Liabilities
14.3B
↓ 2.68%
Q2 FY23Q/Q Change
Total Assets
17.0B
↑ 1.38%
Total Liabilities
14.3B
↑ 0.14%
Q3 FY23Q/Q Change
Total Assets
16.9B
↓ 0.18%
Total Liabilities
14.1B
↓ 1.57%
Q4 FY23Q/Q Change
Total Assets
17.6B
↑ 4.08%
Total Liabilities
14.9B
↑ 5.47%
FY18Y/Y Change
Operating Cash Flow
1.8B
↓ 7.12%
Investing Cash Flow
-1.0B
↓ 26.42%
Financing Cash Flow
-625.4M
↓ 18.39%
FY19Y/Y Change
Operating Cash Flow
2.1B
↑ 16.97%
Investing Cash Flow
3.0B
↓ 397.85%
Financing Cash Flow
-4.7B
↑ 651.01%
FY20Y/Y Change
Operating Cash Flow
2.0B
↓ 4.5%
Investing Cash Flow
-825.4M
↓ 127.56%
Financing Cash Flow
-1.8B
↓ 60.68%
FY21Y/Y Change
Operating Cash Flow
1.9B
↓ 2.43%
Investing Cash Flow
-784.7M
↓ 4.92%
Financing Cash Flow
-1.1B
↓ 41.36%
FY22Y/Y Change
Operating Cash Flow
1.6B
↓ 18.97%
Investing Cash Flow
-630.3M
↓ 19.67%
Financing Cash Flow
-1.1B
↑ 3.52%
Q3 FY22Q/Q Change
Operating Cash Flow
710.5M
↑ 277.7%
Investing Cash Flow
-153.9M
↑ 6.2%
Financing Cash Flow
-445.3M
↑ 330.65%
Q4 FY22Q/Q Change
Operating Cash Flow
343.7M
↓ 51.62%
Investing Cash Flow
-630.3M
↑ 309.71%
Financing Cash Flow
-230.9M
↓ 48.14%
Q1 FY23Q/Q Change
Operating Cash Flow
462.6M
↑ 34.57%
Investing Cash Flow
-116.5M
↓ 81.51%
Financing Cash Flow
-275.9M
↑ 19.49%
Q2 FY23Q/Q Change
Operating Cash Flow
450.1M
↓ 2.69%
Investing Cash Flow
-347.1M
↑ 197.84%
Financing Cash Flow
-96.8M
↓ 64.9%
Q3 FY23Q/Q Change
Operating Cash Flow
661.2M
↑ 46.89%
Investing Cash Flow
-603.5M
↑ 73.86%
Financing Cash Flow
-394.5M
↑ 307.39%

Technicals Summary

Sell

Neutral

Buy

Davita Healthcare Partners Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-6.85%
62.1%
52.88%
15.22%
144.38%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-0.32%
10.42%
-15.35%
-50.85%
-51.82%
Hca Holdings, Inc.
Hca Holdings, Inc.
-4.93%
28.25%
14.58%
59.59%
169.9%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-4.36%
72.26%
44.71%
82.68%
310.08%
Universal Health Services Inc.
Universal Health Services Inc.
-9.74%
24.99%
16.98%
9.58%
28.53%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.49
17.49
1.16
9.01
0.39
0.06
NA
11.89
Fresenius Medical Care Ag
Fresenius Medical Care Ag
20.44
20.44
0.39
2.04
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
17.0
17.0
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.21
17.21
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.27
16.27
1.87
13.45
0.12
0.05
0.0
91.53
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.3B
144.38%
17.49
5.7%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$10.9B
-51.82%
20.44
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$85.3B
169.9%
17.0
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
310.08%
17.21
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.2B
28.53%
16.27
5.03%

Institutional Holdings

  • Berkshire Hathaway Inc

    41.34%

  • Vanguard Group Inc

    7.24%

  • BlackRock Inc

    5.49%

  • State Street Corporation

    2.85%

  • Amvescap Plc.

    1.81%

  • LSV Asset Management

    1.57%

Company Information

about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,

Organization
Davita Healthcare Partners Inc.
Employees
70000
CEO
Mr. Javier J. Rodriguez
Industry
Health Services

Discover More

FAQs